Information Journal Paper
APA:
CopyZHAO, H., & LI, L.. (2016). CONCURRENT PACLITAXEL/CISPLATIN CHEMORADIOTHERAPY WITH OR WITHOUT CONSOLIDATION CHEMOTHERAPY IN HIGH-RISK EARLY-STAGE CERVICAL CANCER PATIENTS FOLLOWING RADICAL HYSTERECTOMY: PRELIMINARY RESULTS OF A PHASE III RANDOMIZED STUDY. ONCOTARGET, 7(43), 70969-70978. SID. https://sid.ir/paper/698984/en
Vancouver:
CopyZHAO H., LI L.. CONCURRENT PACLITAXEL/CISPLATIN CHEMORADIOTHERAPY WITH OR WITHOUT CONSOLIDATION CHEMOTHERAPY IN HIGH-RISK EARLY-STAGE CERVICAL CANCER PATIENTS FOLLOWING RADICAL HYSTERECTOMY: PRELIMINARY RESULTS OF A PHASE III RANDOMIZED STUDY. ONCOTARGET[Internet]. 2016;7(43):70969-70978. Available from: https://sid.ir/paper/698984/en
IEEE:
CopyH. ZHAO, and L. LI, “CONCURRENT PACLITAXEL/CISPLATIN CHEMORADIOTHERAPY WITH OR WITHOUT CONSOLIDATION CHEMOTHERAPY IN HIGH-RISK EARLY-STAGE CERVICAL CANCER PATIENTS FOLLOWING RADICAL HYSTERECTOMY: PRELIMINARY RESULTS OF A PHASE III RANDOMIZED STUDY,” ONCOTARGET, vol. 7, no. 43, pp. 70969–70978, 2016, [Online]. Available: https://sid.ir/paper/698984/en